Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe Hemoglobinopathies
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
MicroRNA Profiles in Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study to Compare a Mono Atezolizumab Window Followed by a Atezolizumab - CTX Therapy With Atezolizumab - CTX Therapy
- Status
- TERMINATED
- Phase
- PHASE2
LCI-BRE-MTN-NIR-001:Ph I Study of Niraparib in Combo With Standard Chemo in Metastatic Trip Neg Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Comparison of Oral Cyclophosphamide vs Doxorubicin in ≥65 Years Old Advanced or Metastatic Soft Tissue Sarcoma Patients
- Status
- RECRUITING
- Phase
- PHASE3
Isatuximab as Upfront Therapy for the Treatment of High Risk AL Amyloidosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
PACIFIC: Primary Mediastinal Large B-cell Lymphoma Treated With Antibody Therapy, Checkpoint Inhibitor in Frontline With ImmunoChemotherapy
- Status
- RECRUITING
- Phase
- PHASE2
Different Immunosuppressive Treatment in iMN
- Status
- RECRUITING
- Phase
- PHASE3
A Phase 1 Study of ADI-001 in B Cell Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Human AntiCD19 Chimeric Antigen Receptor T Cells for Relapsed or Refractory Lymphoid Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Pyrotinib as Neoadjuvant Agent for Non-objective Response HER2-positive Early Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
Decitabine-primed Tandem CD19/CD20 CAR T Cells Treatment in r/r B-NHL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Safety and Efficacy of ALLO-316 in Subjects With Advanced or Metastatic Clear Cell Renal Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT.
- Status
- UNKNOWN
- Phase
- PHASE2
Polatuzumab Vedotin in Combination With Chemotherapy in Subjects With Richter's Transformation
- Status
- RECRUITING
- Phase
- PHASE2
IS-free Treg HaploHCT
- Status
- RECRUITING
- Phase
- PHASE1
Neoadjuvant Study of Camrelizumab Plus Chemotherapy in Triple Negative Breast Cancer (TNBC)
- Status
- UNKNOWN
- Phase
- PHASE2